Full-Time

Clinical Trial Manager/Senior Clinical Trial Manager

Precision AQ

Precision AQ

501-1,000 employees

Data-driven drug access and launches

Compensation Overview

$110.7k - $200.9k/yr

+ Annual bonus

Remote in USA

Remote

Travel domestically and internationally, including overnight stays, is required.

Bachelor's

Category
Biology & Biotech (1)
Required Skills
Microsoft Office
Word/Pages/Docs
Quality Assurance (QA)
Risk Management
Excel/Numbers/Sheets
Microsoft Outlook
PowerPoint/Keynote/Slides

Get referred to Precision AQ

See people who can refer or advise you

Requirements
  • A bachelor's degree or equivalent combination of education and experience in a science or health-related field is required.
  • A minimum of 7 years of clinical research experience or proven competencies for the position, including significant clinical monitoring experience, is required.
  • Experience with Microsoft Office products, including Outlook, Word, Excel, and PowerPoint, is required.
  • The ability to travel domestically and internationally, including overnight stays, is required.
  • Mastery of ICH-GCP, relevant Precision standard operating procedures, and regulatory guidance is required.
  • Working knowledge of clinical management techniques and tools is required.
  • Direct work experience in a cross-functional environment is required.
  • Proven experience in functional management, including delegation while fostering cohesive team dynamics, is required.
  • Proven experience in planning, risk management, and change management is required.
  • In-depth proven experience in pharmaceutical and/or device research is required.
  • Demonstrated successful independent negotiation and conflict management strategies are required.
Responsibilities
  • Serve as the clinical trial lead responsible for planning, conducting, and overseeing the operational portion of clinical studies according to the defined scope of work.
  • Ensure clinical studies are conducted in accordance with the protocol, standard operating procedures, ICH-GCP, and applicable regulatory requirements.
  • Serve as the primary clinical point of contact with the client.
  • Collaborate with the project manager on monthly invoicing and clinical budget variance management.
  • Develop study-related clinical documents, including clinical plans, informed consent form templates, study-specific forms and manuals, case report form completion guidelines, study trackers, PSV/SIV slides, and other training materials.
  • Identify and develop study-specific training needs for clinical research associates and third-party vendors, including presenting training at investigator meetings and study kick-off meetings.
  • Generate potential site lists from key stakeholders and drive the site feasibility process.
  • Identify potential risks to enrollment targets based on feasibility analysis and sites' contracted commitments.
  • Develop and finalize country recruitment and retention strategies.
  • Develop timely and effective communication and working relationships with investigators and the study team to support feasibility, site start-up, enrollment, maintenance, and closeout procedures.
  • Lead internal clinical team meetings and set expectations for the clinical team of clinical research associates and clinical trial assistants.
  • Address clinical research associate and site questions and maintain the frequently asked questions log as appropriate.
  • Support planning and conducting investigator meetings.
  • Review and/or approve investigational product release packages.
  • Oversee, support, and track submissions and approvals to competent authorities and institutional review boards or ethics committees with regulatory departments as applicable.
  • Develop clinical monitoring strategies to ensure study timelines are met and deliverables meet quality standards.
  • Generate and use metric reporting, including clinical trial management system reports, data management query trends, and outstanding monitoring reports, to ensure the study is conducted according to plan and communicate issues to the project manager and clinical research associates.
  • Implement and manage the electronic trial master file.
  • Collaborate with the project manager, clinical research associates, and quality assurance to develop corrective and preventive action plans and ensure their implementation and timely closure.
  • Assist sites, internal staff, and clinical research associates with preparation for Good Clinical Practice audits.
  • Work with the project manager on project-specific resourcing issues.
  • Escalate pertinent clinical research associate performance and site compliance issues when necessary.
  • Collaborate with data management and clinical research associates to ensure data quality and compliance with data-cleaning timelines.
  • Manage investigational product processes, including drug accountability and reconciliation.
  • Assume project management responsibility as needed when a cross-functional project manager is not assigned to a program.
  • Support business development and marketing activities as appropriate.
  • Negotiate site budgets and investigator contracts when applicable, with support from legal or the site contracts group.
  • Review site visit reports when applicable and ensure monitoring scheduling and scope are executed according to the monitoring plan.
  • Manage clinical vendors such as laboratories, investigational product vendors, patient diary vendors, and home health care providers when applicable, in conjunction with the project manager.
  • Perform clinical data review of patient profiles, data listings, and summary tables, including query generation, when applicable.
  • Perform other duties assigned by management.
Desired Qualifications
  • An advanced degree is preferred.

Precision AQ helps pharmaceutical companies get FDA-approved medicines to patients by using data, evidence, and market insights to shape access and launches. Its services combine medical science, commercial strategy, and technology development to create new pathways for drug availability and timely delivery. The company partners with drug makers to plan launches and expansion, using analytical and creative approaches to make medicines reachable and effective in real-world settings. Unlike firms that focus only on science or marketing, Precision AQ blends data-driven insights with strategic execution across development and commercialization to accelerate patient access. The goal is to raise standards in healthcare accessibility and impact by getting the right medicines to the right patients faster.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

New York City, New York

Founded

N/A

Get referred to Precision AQ

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Precision AQ says it serves all 30 top pharma companies and launched 450-plus drugs.
  • April 25, 2025 oncology hires sharpen payer, provider, and formulary strategy for launches.
  • May 28, 2026 ASCO materials showcase OncoGenius and Navigator365 Matrix with 100-plus cancer centers.

What critics are saying

  • IQVIA, ICON, and Syneos Health crowd Precision AQ’s commercialization niche globally.
  • AI patient-services commoditization from Phluence-style tools compresses consulting margins by 2027.
  • Reliance on pharma launch budgets creates existential exposure if one major client insources access strategy.

What makes Precision AQ unique

  • Precision AQ’s AET has 25-plus former access decision-makers, built since 2009.
  • February 17, 2026 hires Emma Hawe and Yahya Anvar deepen HEOR, AI, and EU reach.
  • November 18, 2025 Phluence investment extends agentic post-Rx automation beyond traditional HUB models.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Life Insurance

Disability Insurance

Paid Vacation

Paid Sick Leave

Parental Leave

Performance Bonus

Company News

PR Newswire
Feb 17th, 2026
Precision AQ expands leadership with AI and data strategy hires to strengthen global biopharma solutions

Precision AQ, a global life sciences commercialisation partner, has appointed two senior leaders to expand its AI and data capabilities. Emma Hawe joins as Senior Vice President, Managing Director for Evidence Synthesis & Decision Modelling, bringing over 25 years of experience in evidence generation and applied statistics. She currently chairs ISPOR's HEOR Excellence—Methodology Award. Yahya Shaikh becomes Senior Vice President, Data Strategy & AI, focusing on strengthening the company's data foundation and advancing AI-enabled solutions. He brings decades of experience in AI, analytics and enterprise data strategy across life sciences and healthcare. The appointments aim to bolster Precision AQ's presence in the EU whilst expanding its global reach. The company works with all 30 top pharmaceutical firms and has launched over 450 drugs across therapeutic areas.

StreetInsider
Nov 18th, 2025
Precision AQ Invests in Phluence Platform

Precision AQ has made a strategic investment in Phluence, enhancing its post-prescription capabilities. This investment allows pharmaceutical manufacturers to virtualize patient services, reduce costs, and improve access through Phluence's advanced agentic workflow management platform. The collaboration aims to modernize patient engagement with AI-driven solutions, offering an alternative to traditional HUB models. This move supports Precision AQ's goal to streamline patient services and accelerate access to therapies.

PR Newswire
Apr 25th, 2025
Precision Aq Expands Industry-Leading Access Experience Team (Aet) With Three Oncology Experts

-- Shraddha Kansagra, PharmD, BCOP, former Clinical Pharmacy Specialist at UT Southwestern, appointed Vice President, Clinical Oncology Solutions ---- Angelica Norrell, PharmD, BCOP, CSP, former Senior Director of Product at Optum, joins as Senior Director, AET ---- Courtney Patterson, PharmD, MBA, former System Director of Oncology Pharmacy Services at Advocate Health, joins as Vice President, Clinical Oncology Solutions --NEW YORK, April 25, 2025 /PRNewswire/ -- Precision AQ, a leader in life sciences commercialization and a driving force in expanding patient access to life-changing therapies, today announced the additions of Shraddha Kansagra, PharmD, BCOP, Angelica Norrell, PharmD, BCOP, CSP, and Courtney Patterson, PharmD, MBA to its Access Experience Team (AET). These experts join Precision AQ's AET, an industry-leading team of former access decision-makers and influencers, to provide critical insights to life science companies and support them in anticipating payer challenges and designing strategies to optimize patient access in oncology.As access decisions in oncology increasingly incorporate both payer and provider perspectives, the additions of Drs. Kansagra, Norrell, and Patterson reflect Precision AQ's commitment to evolving with the landscape. Precision AQ's AET boasts numerous oncology experts, including five Board Certified Oncology Pharmacists (BCOPs), from prominent payer and provider-based institutions across the United States. These new additions further bolster the AET's expertise and capabilities, including driving medical and pharmacy benefit management for Value Based Care, drug coverage policy and formulary design; optimizing patient care through quality improvement initiatives; and overseeing pharmacy and healthcare operations."We are delighted to welcome Shraddha, Angie, and Courtney to Precision AQ, bolstering our AET with additional expertise in oncology, one of the most innovative areas in healthcare," said Chad Clark, President and Chief Operating Officer of Precision Medicine Group. "Together with our existing roster of top-tier access decision makers, as well as our external network of over 100 oncology advisors from leading U.S

PR Newswire
Mar 31st, 2025
Precision Aq Earns Hitrust Implemented, 1-Year I1 Certification For Data Protection And Cybersecurity Risk Management

HITRUST i1 certification confirms Precision AQ's commitment to protecting sensitive data with leading security practices.NEW YORK, March 31, 2025 /PRNewswire/ -- Precision AQ, a leader in guiding life science organizations through the complexities of product commercialization and empowering access to life-changing medicines for all, announced today that its PatientLens platform has achieved HITRUST certification for system and information security.PatientLens transforms healthcare insights and patient program design by reducing friction in patient services and by delivering timely, actionable information to support decision-making. The platform offers a detailed view of insurance coverage, out-of-pocket costs, and medical or medication history. By leveraging tokenized patient data and advanced analytics, PatientLens helps healthcare organizations optimize patient outreach, prioritize cases, and ensure compliance, driving improved outcomes and operational efficiency.The HITRUST Implemented, 1-Year i1 validated assessment and certification process confirms that the PatientLens platform applies a robust set of HITRUST-curated controls. These controls ensure the organization follows leading security practices and maintains a comprehensive cybersecurity program to defend against cyber threats. HITRUST continuously analyzes cyber threat intelligence to keep its control requirements relevant, helping organizations mitigate emerging risks like phishing, brute force attacks, and ransomware, and supporting organizational resilience."The HITRUST i1 validated assessment is a powerful tool for cyber-aware organizations, such as Precision AQ," said Robert Booker, Chief Strategy Officer at HITRUST. "This certification assures the measurement, implementation, and performance of robust information security controls

GlobeNewswire
Mar 4th, 2025
Tenaya Therapeutics Announces Pricing of Public Offering

SOUTH SAN FRANCISCO, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage biotechnology company with a...